A series of government actions have evolved since the 1990s to facilitate the development of medicinal products for pediatric use using a combination of incentives and mandates. The initiatives have been successful in stimulating activity and interest in products developed for pediatric use. The initiatives continue to evolve as experience accumulates and regulatory agencies develop robust cooperative programs. A multidimensional program is necessary to achieve the necessary goal of aligning pediatric therapeutics with adult therapeutics and providing children the most favorable opportunity to benefit and minimize risk to vulnerable populations. © 2011 Springer-Verlag Berlin Heidelberg.
CITATION STYLE
Hirschfeld, S., & Saint-Raymond, A. (2011). Pediatric regulatory initiatives. Handbook of Experimental Pharmacology, 205, 245–268. https://doi.org/10.1007/978-3-642-20195-0_12
Mendeley helps you to discover research relevant for your work.